A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A Open-label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics
and Safety between a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin versus
Co-administration of a Fixed Dose Combination of Fimasartan/Amlodipine and Rosuvastatin in
Healthy Male Subjects.